Imperious Group

About The Fund

Imperious Group is a specialized venture capital firm that focuses on pre-seed, seed, and series A stage investments. Founded in 2010, the firm primarily invests in companies operating in software as a service (SaaS), mobile products, online education, e-commerce, financial services, and big data sectors. They have composed an early-stage venture capital fund valued at approximately $25 million and prefer investing in startups whose research and development bases are located in Central and Eastern Europe (CEE), particularly Ukraine, or Israel. Imperious Group targets teams with products designed for global markets, including Europe, USA, and Asia. While they do not intervene in the day-to-day operational processes of the companies they invest in, they do require regular reporting. The firm does not set industry limitations for their investments but shows a predilection for startups specializing in AI/ML, VR/AR, EdTech, AdTech, Digital Health, SaaS, FinTech, and Blockchain. Their typical investment ranges from $50K to $200K for the seed stage and can reach $1M for series A rounds. Imperious Group boasts a portfolio of over 40 companies, many of which are raising their first round A rounds and are in the stage of active growth. The firm's portfolio companies operate in 10 countries and 17 cities, offering insights into global scaling techniques. Some of their early-stage investments have garnered support from top-tier funds like Andreessen Horowitz, Greycroft Partners, FJ Labs, and Metamorphic Ventures in subsequent funding rounds. The firm prides itself on providing more than just capital by offering strategic guidance, a robust network of resources, and perks like Amazon AWS credits, along with connections to talent in AI/ML and Blockchain, to support the development and growth of their portfolio companies. Moreover, Imperious Group includes IG Science, a division dedicated to advancing scientific discoveries and breakthrough technologies in various fields through collaboration with scientists, researchers, and academic institutions. They provide critical funding, expertise, and support for commercializing scientific and technological innovations. They are actively open to co-investing with other funds or becoming the lead investor in disruptive deals, as well as assisting startups with setting up research and development in CEE including Ukraine, commercialization of patents, and planning for the US market entry.